The China-based cancer drug developer’s offering will fund testing of medicines for several blood malignancies — one of which is part of an alliance with Takeda.
Roche plans to release the system in the US to run tests including vitamin D and steroid assays under CLIA before it possibly receives US Food and Drug Administration clearance.
New research - led by the University of Portsmouth in collaboration with the University of Southampton, King’s College London, and the Massachusetts Institute of Technology - has developed a set of ...